Limit this search to....

Resistance to Targeted Therapies Against Adult Brain Cancers
Contributor(s): Tivnan, Amanda (Editor)
ISBN: 331946504X     ISBN-13: 9783319465043
Publisher: Springer
OUR PRICE:   $161.49  
Product Type: Hardcover - Other Formats
Published: December 2016
Qty:
Additional Information
BISAC Categories:
- Medical | Oncology - General
- Medical | Forensic Medicine
Dewey: 614.599
Series: Resistance to Targeted Anti-Cancer Therapeutics
Physical Information: 0.69" H x 6.14" W x 9.21" (1.25 lbs) 260 pages
 
Descriptions, Reviews, Etc.
Publisher Description:

This volume will bring together a review of research being carried out by international experts in this field, detailing treatment and research approaches in several forms of malignant brain tumors. These include glioblastoma (GBM), a highly aggressive and fatal form of astrocytoma which accounts for 80% of newly diagnosed brain tumor patients per year, and meningioma, of which 10% are malignant and extremely resistant to targeted therapies. The volume will also include a discussion of methods to overcome blood-brain barrier exclusion for more efficient targeted drug delivery in all forms of brain cancer treatment. The volume will include information on the repurposing of drugs in an attempt to circumvent drug resistance, use of small molecule inhibitors in GBM treatment, mechanisms of secondary brain metastasis, drug resistance, and state-of-the-art imaging of targeted therapies.